B-FLEXION FUND MANAGEMENT (JERSEY) LIMITED

The B-Flexion name is strongly associated with the Bertarelli family's private investment group, which was formed after the 2006 sale of Serono to Merck KGaA for approximately $13.3 billion. However, the specific Jersey entity has not publicly confirmed its ownership or operational relationship to the parent group. Any connection remains a matter of inference from naming convention and jurisdictional pattern rather than verified public disclosure.

Jersey offers a regulated fund regime that is widely used by European family offices and private investment firms for its combination of regulatory credibility, tax neutrality, and experienced service-provider ecosystem. The jurisdiction allows managers to operate collective investment schemes and private fund structures while maintaining confidentiality of investor identities and portfolio holdings, which aligns with the entity's observed low public profile.

The firm's registration in Jersey as a fund management company suggests it may have the regulatory permissions to manage external investor capital, but no fund prospectuses, offering documents, or marketing materials are publicly available. Without those disclosures, it is impossible to determine whether the entity operates as a dedicated single-family vehicle or manages pooled third-party funds.

No public disclosures specify the firm's asset allocation. Entities in the broader B-Flexion group historically have been associated with private equity, real estate, and direct company holdings, but the Jersey entity's specific investment mandate has not been published in any regulatory filing, press release, or trade publication.

No named principals have been publicly disclosed. Jersey company registries typically list directors and officers, but the firm has not issued press releases, media statements, or team biographies identifying its investment decision-makers. The operational leadership remains unconfirmed in any identifiable public source.